Duopharma Biotech Berhad 7148.KL Stock
Duopharma Biotech Berhad Price Chart
Duopharma Biotech Berhad 7148.KL Financial and Trading Overview
Duopharma Biotech Berhad stock price | 1.18 MYR |
Previous Close | 1.33 MYR |
Open | 1.32 MYR |
Bid | 1.33 MYR x 0 |
Ask | 1.35 MYR x 0 |
Day's Range | 1.31 - 1.35 MYR |
52 Week Range | 1.06 - 1.68 MYR |
Volume | 73K MYR |
Avg. Volume | 259.79K MYR |
Market Cap | 1.3B MYR |
Beta (5Y Monthly) | 0.713698 |
PE Ratio (TTM) | 16.875 |
EPS (TTM) | 0.06 MYR |
Forward Dividend & Yield | 0.02 (1.70%) |
Ex-Dividend Date | April 6, 2023 |
1y Target Est | 1.78 MYR |
7148.KL Valuation Measures
Enterprise Value | 1.59B MYR |
Trailing P/E | 16.875 |
Forward P/E | 12.272728 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.8258276 |
Price/Book (mrq) | 1.9230769 |
Enterprise Value/Revenue | 2.24 |
Enterprise Value/EBITDA | 12.594 |
Trading Information
Duopharma Biotech Berhad Stock Price History
Beta (5Y Monthly) | 0.713698 |
52-Week Change | 12.71% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.68 MYR |
52 Week Low | 1.06 MYR |
50-Day Moving Average | 1.45 MYR |
200-Day Moving Average | 1.48 MYR |
7148.KL Share Statistics
Avg. Volume (3 month) | 259.79K MYR |
Avg. Daily Volume (10-Days) | 193.46K MYR |
Shares Outstanding | 961.94M |
Float | 451.16M |
Short Ratio | N/A |
% Held by Insiders | 60.04% |
% Held by Institutions | 8.78% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.023 |
Trailing Annual Dividend Yield | 1.72% |
5 Year Average Dividend Yield | 259.00% |
Payout Ratio | 0.5409 |
Last Split Factor | 4:3 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 10.18% |
Operating Margin (ttm) | 13.40% |
Gross Margin | 40.27% |
EBITDA Margin | 17.78% |
Management Effectiveness
Return on Assets (ttm) | 4.87% |
Return on Equity (ttm) | 11.10% |
Income Statement
Revenue (ttm) | 711.25M MYR |
Revenue Per Share (ttm) | 0.75 MYR |
Quarterly Revenue Growth (yoy) | 7.79% |
Gross Profit (ttm) | 279.82M MYR |
EBITDA | 126.52M MYR |
Net Income Avi to Common (ttm) | 72.45M MYR |
Diluted EPS (ttm) | 0.08 |
Quarterly Earnings Growth (yoy) | 11.50% |
Balance Sheet
Total Cash (mrq) | 127.88M MYR |
Total Cash Per Share (mrq) | 0.13 MYR |
Total Debt (mrq) | 435.78M MYR |
Total Debt/Equity (mrq) | 65.16 MYR |
Current Ratio (mrq) | 2.036 |
Book Value Per Share (mrq) | 0.702 |
Cash Flow Statement
Operating Cash Flow (ttm) | 29.2M MYR |
Levered Free Cash Flow (ttm) | -44709376 MYR |
Profile of Duopharma Biotech Berhad
Country | Malaysia |
State | N/A |
City | Kuala Lumpur |
Address | CIMB HUB |
ZIP | 50250 |
Phone | 60 3 2162 0218 |
Website | https://duopharmabiotech.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 1650 |
Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables to patients with conditions, such as diabetes, cancer, cardiovascular diseases, renal diseases, and others. The company's product portfolio comprises vascor, acetan, covasc, crystorvas, bezartan, vytan, and vytocor; insugen and basalog one; kytron, zuhera, lebreta, trevive, and krabeva; and unihepa, ranofer, erysaa, bi-haemosol, and haemosol. The company offers its products under the Champs, Flavettes, Eye Glo, Proviton, Naturalle, and Uphamol brands. In addition, it offers property management and services; and distributes, imports, and exports chemical products. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. The company was founded in 1978 and is headquartered in Kuala Lumpur, Malaysia.
Q&A For Duopharma Biotech Berhad Stock
What is a current 7148.KL stock price?
Duopharma Biotech Berhad 7148.KL stock price today per share is 1.18 MYR.
How to purchase Duopharma Biotech Berhad stock?
You can buy 7148.KL shares on the Kuala Lumpur exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Duopharma Biotech Berhad?
The stock symbol or ticker of Duopharma Biotech Berhad is 7148.KL.
Which industry does the Duopharma Biotech Berhad company belong to?
The Duopharma Biotech Berhad industry is Drug Manufacturers-Specialty & Generic.
How many shares does Duopharma Biotech Berhad have in circulation?
The max supply of Duopharma Biotech Berhad shares is 961.94M.
What is Duopharma Biotech Berhad Price to Earnings Ratio (PE Ratio)?
Duopharma Biotech Berhad PE Ratio is 19.66666600 now.
What was Duopharma Biotech Berhad earnings per share over the trailing 12 months (TTM)?
Duopharma Biotech Berhad EPS is 0.06 MYR over the trailing 12 months.
Which sector does the Duopharma Biotech Berhad company belong to?
The Duopharma Biotech Berhad sector is Healthcare.